Home - Products - GPCR/G Protein - Prostaglandin Receptor - Triacontanol

Triacontanol

CAS No. 28351-05-5

Triacontanol( —— )

Catalog No. M18360 CAS No. 28351-05-5

1-Triacontanol is a fatty alcohol of the general formula C30H62O, also known asmelissyl alcoholormyricyl alcohol. It is found in plantcuticle waxesand inbeeswax.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
10MG	45	In Stock
25MG	73	In Stock
100MG	140	In Stock
200MG	252	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Triacontanol
Note

Research use only, not for human use.
Brief Description

1-Triacontanol is a fatty alcohol of the general formula C30H62O, also known asmelissyl alcoholormyricyl alcohol. It is found in plantcuticle waxesand inbeeswax.
Description

1-Triacontanol is a fatty alcohol of the general formula C30H62O, also known asmelissyl alcoholormyricyl alcohol. It is found in plantcuticle waxesand inbeeswax. Triacontanol is agrowth stimulantfor many plants, most notablyroses, in which it rapidly increases the number of basal breaks.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

GPCR/G Protein
Target

Prostaglandin Receptor
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

28351-05-5
Formula Weight

438.82
Molecular Formula

C30H62O
Purity

>98% (HPLC)
Solubility

——
SMILES

CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Li X, et al. Bioorg Med Chem Lett. 2011, 21(18):5251-4.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

OBE022

OBE022 is a potent, highly selective, orally active antagonist of the contractile PGF2α prostaglandin receptor with Kb of 5.9 nM.
Tafluprost

Tafluprost, a prostaglandin analog, is the selective agonist of fluoroprostaglandin (FP) receptor PGF2α.Tafluprost showed significant IOP-lowering effects without any safety concerns in patients with various types of glaucoma and OH in daily clinical practice and tafluprost is highly effective in any therapeutic pattern.
Asapiprant

Asapiprant (S-555739) is a potent and selective DP1 receptor antagonist (Ki: 0.44 nM). It exhibited high affinity and selectivity for the DP1 receptor.

Sign In Join Free